Evidence map›Paper›PMID 40820830›Full record

ArticleTurkish archives of pediatrics2025

Association of Poverty Income Ratio with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis Among US Population.

Wenying Guo, Ting Weng, Yufei Song

Abstract read
In one paragraph

Article in Turkish archives of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wenying Guohttps://orcid.org/0009-0002-0788-5932.ORCID 0009-0002-0788-5932
Ting Wenghttps://orcid.org/0009-0002-0788-5932.ORCID 0009-0007-9104-3610
Yufei Songhttps://orcid.org/0009-0002-0788-5932.ORCID 0000-0002-3874-8722

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a recent update in defining fatty liver disease, emphasizing its strong connection to metabolic factors and reflecting a shift in understanding its causes and progression. The principal aim of this investigation was to scrutinize the conceivable association between the poverty income ratio (PIR) and the incidence of MASLD, specifically focusing on liver fibrosis. Materials and Methods: In this study, a cross-sectional analysis was carried out utilizing data obtained from the National Health and Nutrition Examination Survey dataset covering the period from 2017 to 2020. To explore the relationship between the PIR and the prevalence of MASLD as well as liver fibrosis, a robust multivariable analytical method was adopted. This approach integrated a wide range of variables, such as sociodemographic characteristics, lifestyle habits, and individual health conditions. Results: In this study, a comprehensive analysis was conducted using logistic regression models and found a significant decline in the likelihood of MASLD in the highest PIR quartile (Q4) (odds ratio [OR] = 0.634, 95% CI: 0.446-0.903, P = .012) as well as liver fibrosis (OR = 0.682, 95% CI: 0.503-0.925, P = .014). Conclusion: The findings obtained from this research strongly demonstrate that higher PIR levels are significantly associated with a reduced prevalence of both MASLD and liver fibrosis, suggesting that higher socioeconomic shighertatus, as reflected by higher PIR, may decrease the risk of these conditions. These findings underscore the need for targeted interventions, such as better nutrition education, lifestyle support, and healthcare access to reduce the MASLD burden in low-income populations.

Identifiers

PMID40820830
PMCPMC12351293

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.